Skip to content

Functional Electrical Stimulation of Peripheral Muscles in Heart Failure With Preserved Left Ventricular Ejection Fraction

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01829607
Enrollment
30
Registered
2013-04-11
Start date
2011-01-31
Completion date
Unknown
Last updated
2013-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure With Preserved Left Ventricular Ejection Fraction

Brief summary

The purpose of this study is to evaluate the effects of functional electrical stimulation of peripheral muscles on clinical and emotional status, endothelial function and left ventricular diastolic function in heart failure with preserved left ventricular ejection fraction.

Interventions

OTHERFunctional electrical stimulation of peripheral muscles

Sponsors

Attikon Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

(i) symptoms \[New York Heart Association (NYHA) class II or III\] and signs typical of heart failure (ii) left ventricular (LV) ejection fraction (LVEF) \>50% and LV end-diastolic volume index \<97 mL/m2 (iii) findings of left atrial (LA) dilatation (LA volume index \>40mL/m2), LV hypertrophy and/or LV diastolic dysfunction \[ie, mitral E/A ratio \<1 or \>2, mitral E/e' ratio \>15 or 8-15, (A pulmonary - A mitral) duration difference \>30 ms etc) (iv) no alterations in medical therapy during the previous 4 weeks (v) no myocardial infarction within 3 months prior to enrollment

Exclusion criteria

recent (≤4 weeks) heart failure decompensation * acute coronary syndrome * chronic inflammatory diseases and malignancies

Design outcomes

Primary

MeasureTime frame
Exercise capacitySix weeks
Quality of lifeSix weeks
Emotional statusSix weeks

Secondary

MeasureTime frame
Left ventricular diastolic functionSix weeks
Endothelial functionSix weeks

Other

MeasureTime frame
Neurohormonal activationSix weeks

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026